These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 20037174)
1. Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription. Habib AM; Preston E; Davenport A Nephrol Dial Transplant; 2010 May; 25(5):1633-8. PubMed ID: 20037174 [TBL] [Abstract][Full Text] [Related]
2. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients. Moriishi M; Kawanishi H; Tsuchiya S Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933 [TBL] [Abstract][Full Text] [Related]
3. The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made. Lambie ML; John B; Mushahar L; Huckvale C; Davies SJ Kidney Int; 2010 Sep; 78(6):611-8. PubMed ID: 20571473 [TBL] [Abstract][Full Text] [Related]
4. Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients After Kidney Transplantation. Ayar Y; Ersoy A; Ocakoglu G; Gullulu E; Kagızmanlı H; Yıldız A; Oruc A; Yavuz M; Gullulu M; Dilek K Transplant Proc; 2018; 50(1):160-164. PubMed ID: 29407302 [TBL] [Abstract][Full Text] [Related]
5. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group. Shroff R; Stefanidis CJ; Askiti V; Edefonti A; Testa S; Ekim M; Kavaz A; Ariceta G; Bakkaloglu S; Fischbach M; Klaus G; Zurowska A; Holtta T; Jankauskiene A; Vondrak K; Vande Walle J; Schmitt CP; Watson AR; Nephrol Dial Transplant; 2013 Jul; 28(7):1908-14. PubMed ID: 23348882 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for encapsulating peritoneal sclerosis in long-term peritoneal dialysis: a retrospective observational study. Nakao M; Yokoyama K; Yamamoto I; Matsuo N; Tanno Y; Ohkido I; Hayakawa H; Ikeda M; Yamamoto H; Hosoya T Ther Apher Dial; 2014 Feb; 18(1):68-73. PubMed ID: 24499086 [TBL] [Abstract][Full Text] [Related]
7. Prospective multicenter observational study of encapsulating peritoneal sclerosis with neutral dialysis solution--the NEXT-PD study. Kawanishi H; Nakayama M; Miyazaki M; Honda K; Tomo T; Kasai K; Nakamoto H; Adv Perit Dial; 2010; 26():71-4. PubMed ID: 21348384 [TBL] [Abstract][Full Text] [Related]
8. Sodium removal in peritoneal dialysis: the role of icodextrin and peritoneal dialysis modalities. Fourtounas C; Hardalias A; Dousdampanis P; Papachristopoulos B; Savidaki E; Vlachojannis JG Adv Perit Dial; 2008; 24():27-31. PubMed ID: 18985997 [TBL] [Abstract][Full Text] [Related]
9. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis. Vidal E; Edefonti A; Puteo F; Chimenz R; Gianoglio B; Lavoratti G; Leozappa G; Maringhini S; Mencarelli F; Pecoraro C; Ratsch IM; Cannavò R; De Palo T; Testa S; Murer L; Verrina E; Nephrol Dial Transplant; 2013 Jun; 28(6):1603-9. PubMed ID: 23585587 [TBL] [Abstract][Full Text] [Related]
10. Posttransplant encapsulating peritoneal sclerosis: presentation of cases and review of the literature. Dębska-Ślizien A; Konopa J; Januszko-Giergielewicz B; Wołyniec Z; Wołyniec W; Chamienia A; Rutkowski B J Nephrol; 2013; 26(5):906-11. PubMed ID: 23065918 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355 [TBL] [Abstract][Full Text] [Related]
13. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution. Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820 [TBL] [Abstract][Full Text] [Related]
14. Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study. Nakayama M; Miyazaki M; Honda K; Kasai K; Tomo T; Nakamoto H; Kawanishi H Perit Dial Int; 2014; 34(7):766-74. PubMed ID: 24497585 [TBL] [Abstract][Full Text] [Related]
15. Can radiological assessment of abdominal computerized scans diagnose encapsulating peritoneal sclerosis in long-term peritoneal dialysis patients? Stuart S; Stott D; Goode A; Cash CJ; Davenport A Nephrology (Carlton); 2017 Jan; 22(1):19-24. PubMed ID: 26730546 [TBL] [Abstract][Full Text] [Related]
16. Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients. Alatab S; Najafi I; Pourmand G; Hosseini M; Shekarchian S Ren Fail; 2017 Nov; 39(1):32-39. PubMed ID: 27774831 [TBL] [Abstract][Full Text] [Related]
17. Peritoneal dialysis patients with high effluent fibrin degradation products. Moriishi M; Kawanishi H; Tsuchiya S Adv Perit Dial; 2009; 25():41-4. PubMed ID: 19886315 [TBL] [Abstract][Full Text] [Related]
18. Effects of icodextrin on the peritoneal membrane. Krediet RT Nephrol Dial Transplant; 2010 May; 25(5):1373-5. PubMed ID: 20172851 [No Abstract] [Full Text] [Related]
19. A case of encapsulating peritoneal sclerosis suspected to result from the use of icodextrin peritoneal solution. Kawanishi H; Shintaku S; Shishida M; Morrishi M; Tsuchiya S; Dohi K Adv Perit Dial; 2009; 25():45-9. PubMed ID: 19886316 [TBL] [Abstract][Full Text] [Related]
20. The peritoneal sieving of sodium: a simple and powerful test to rule out the onset of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis. La Milia V; Longhi S; Sironi E; Pontoriero G J Nephrol; 2018 Feb; 31(1):137-145. PubMed ID: 28012100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]